Table 1: Baseline demographic and characteristics of the 62 patients enrolled in this study.

NBP IH p-value
Patient n (%) 53 (85) 9 (15)
Gender n (%) Men 32 (60) 5 (56) 0.999
Women 21 (40) 4 (44)
Age (y) 74[63-80] 75[61-80] 0.734
Maintenance dialysis duration (y) 8.05 ± 4.07 8.33 ± 3.33 0.885
Session duration (Hours) 4.2 [4, 5] 4.1[4-4.4] 0.063
Antihypertensive medications n (%) ARB 14 (26) 2 (22) 0.999
β blockers 34 (64) 7 (77) 0.705
CCB 34 (64) 9 (100) 0.464
α 1 blockers 15 (28) 1 (11) 0.670
α and β blocking agents 2 (3) 0 (0) 0.999
Diuretics 19 (35) 2 (22) 0.705
Vasodilators 12 (22) 0 (0) 0.185
ARB + CCB 11 (20) 1 (11) 0.675
Nephropathy causes n (%) Hypertension 20 (38) 3 (33) 0.999
Diabetes mellitus 15 (28) 1 (11) 0.425
Glomerulonephritis 7 (13) 4 (45) 0.044
Polycystic disease 4 (8) 0 (0) 0.999
Chronic tubulo-interstitial nephritis 4 (8) 0 (0) 0.999
Unknown 3 (5) 1 (11) 0.475

ARB: angiotensin II receptor blocker; CCB: calcium channel blockers; n: number of patients in each group, y: years. Data are represented as mean ± SD or as median with its interquartile range (IQR = Q1- Q3). The T-test, Mann-Whitney U test and Fisher exact test were used as appropriate.